Regeneron 23andMe Acquisition

News

Anne Wojcicki to buy back 23andMe and its data

Anne Wojcicki to buy back 23andMe and its data for $305 million

TTAM will acquire substantially all of 23andMe’s assets for $305 million, including its Personal Genome Service and Research Services business lines as well as telehealth subsidiary Lemonaid Health. It’s a big win for Wojcicki, who stepped down from her role as CEO when 23andMe filed for Chapter 11 bankruptcy protection in March.

· 7h · on MSN

23andMe founder Anne Wojcicki will regain control of embattled DNA company after all

· 2h · on MSN

Anne Wojcicki is taking back control of 23andMe

TMCnet8h

23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process

SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered ...

ConsumerAffairs3d

States file suit to block the sale of 23andMe data

D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...

Lawmakers question 23andMe executive on what sale means for genetic data

Lawmakers want to know what will be done to make sure consumer genetic testing company 23andMe’s data will stay out of the ...

12d

23andMe founder says Fortune 500 company backs new buyout offer

The founder of 23andMe has asked a federal bankruptcy court judge to reopen an auction for the genetic testing company, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results